M.C. Mathieu
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 3
-
- Breast Lesions and Carcinomas 3
- Co-authors
- M. Spielmann (2 shared papers)Suzette Delaloge (2 shared papers)Serge Koscielny (1 shared paper)Antonio Llombart‐Cussac (1 shared paper)G Contesso (1 shared paper)Roman Rouzier (1 shared paper)J.P. Travagli (1 shared paper)Lucas Sidéris (1 shared paper)
- Journals
- European Journal of Pharmaceutical Sciences (2 papers)European Journal of Radiology (2 papers)Anti-Cancer Drugs (1 paper)Breast Cancer Research and Treatment (1 paper)Oncogene (1 paper)
- Partner nations
- FranceUnited KingdomSpain
In The Last Decade
M.C. Mathieu
14 papers receiving 464 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 170
- Oncology 188
- Radiology, Nuclear Medicine and Imaging 147
- Pathology and Forensic Medicine 73
- Dermatology 20
Countries citing papers authored by M.C. Mathieu
This map shows the geographic impact of M.C. Mathieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Mathieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Mathieu more than expected).
Fields of papers citing papers by M.C. Mathieu
This network shows the impact of papers produced by M.C. Mathieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Mathieu. The network helps show where M.C. Mathieu may publish in the future.
Co-authors
The 25 scholars most cited alongside M.C. Mathieu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 142 | |
| 2 | 2012 | 102 | |
| 3 | 2003 | 101 | |
| 4 | 2000 | 44 | |
| 5 | 2011 | 25 | |
| 6 | 2002 | 20 | |
| 7 | [HER2 gene amplification assay: is CISH an alternative to FISH?]. | 2003 | 14 |
| 8 | 2020 | 13 | |
| 9 | 1997 | 8 | |
| 10 | 2003 | 6 | |
| 11 | 1992 | 6 | |
| 12 | 1993 | 5 | |
| 13 | 1996 | 3 | |
| 14 | [Clinical, biological, histological, ultrastructural and therapeutic studies in one case (author's transl)]. | 1980 | 1 |
About M.C. Mathieu
M.C. Mathieu is a scholar working on Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Dermatology, having authored 14 papers that have together received 490 indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (3 papers), HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (2 papers), Electrical and Bioimpedance Tomography (2 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Glycosylation and Glycoproteins Research (1 paper), RNA modifications and cancer (1 paper) and Microfluidic and Bio-sensing Technologies (1 paper). The work is most often cited by research in Cancer Research (170 citations), Oncology (188 citations), Radiology, Nuclear Medicine and Imaging (147 citations), Pathology and Forensic Medicine (73 citations) and Dermatology (20 citations). M.C. Mathieu has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include M. Spielmann, Suzette Delaloge, Serge Koscielny, Antonio Llombart‐Cussac, G Contesso, Roman Rouzier, J.P. Travagli, Lucas Sidéris, C. Bourgier and Corinne Balleyguier. Their work appears in journals such as European Journal of Pharmaceutical Sciences, European Journal of Radiology, Anti-Cancer Drugs, Breast Cancer Research and Treatment and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.